Molecular Detection of the Macrolide Efflux Gene: to Discriminate or Not to Discriminate Between Mef(A) and Mef(E)

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2005 Mar 29

PMID 15793097

Citations 19

Authors

Corne H W Klaassen

Johan W Mouton

Affiliations

Soon will be listed here.

Citing Articles

Characterization and Fitness Cost of Tn, a Novel Integrative and Conjugative Element Conferring Multidrug Resistance in .

Johannessen H, Anthonisen I, Zecic N, Hegstad K, Ranheim T, Skaare D Front Microbiol. 2022; 13:945411.

PMID: 35935209 PMC: 9355037. DOI: 10.3389/fmicb.2022.945411.

Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond.

Alamolhoda S, Zarghami N, Kahroba H, Mehdipour A, Pourhassan-Moghaddam M, Jahanban-Esfahlan R Adv Pharm Bull. 2022; 12(1):58-76.

PMID: 35517891 PMC: 9012923. DOI: 10.34172/apb.2022.004.

Predicted transmembrane proteins with homology to Mef(A) are not responsible for complementing mef(A) deletion in the mef(A)-msr(D) macrolide efflux system in Streptococcus pneumoniae.

Fox V, Santoro F, Pozzi G, Iannelli F BMC Res Notes. 2021; 14(1):432.

PMID: 34823574 PMC: 8620141. DOI: 10.1186/s13104-021-05856-6.

Antimicrobial Resistance Following Azithromycin Mass Drug Administration: Potential Surveillance Strategies to Assess Public Health Impact.

Mack I, Sharland M, Berkley J, Klein N, Malhotra-Kumar S, Bielicki J Clin Infect Dis. 2019; 70(7):1501-1508.

PMID: 31633161 PMC: 7670997. DOI: 10.1093/cid/ciz893.

Prevalence of Various Vaccine Candidate Proteins in Clinical Isolates of : Characterization of the Novel Pht Fusion Proteins PhtA/B and PhtA/D.

Kawaguchiya M, Urushibara N, Aung M, Shinagawa M, Takahashi S, Kobayashi N Pathogens. 2019; 8(4).

PMID: 31554325 PMC: 6963846. DOI: 10.3390/pathogens8040162.

References

Angot P, Vergnaud M, Auzou M, Leclercq R . Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque. Eur J Clin Microbiol Infect Dis. 2000; 19(10):755-8. DOI: 10.1007/pl00011229. View

Fitoussi F, Doit C, Geslin P, Brahimi N, Bingen E . Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob Agents Chemother. 2001; 45(2):636-8. PMC: 90344. DOI: 10.1128/AAC.45.2.636-638.2001. View

Jasir A, Tanna A, Efstratiou A, Schalen C . Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden. J Clin Microbiol. 2001; 39(2):586-90. PMC: 87780. DOI: 10.1128/JCM.39.2.586-590.2001. View

Weiss K, de Azavedo J, Restieri C, Galarneau L, Gourdeau M, Harvey P . Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. J Antimicrob Chemother. 2001; 47(3):345-8. DOI: 10.1093/jac/47.3.345. View

McGee L, Klugman K, Wasas A, Capper T, Brink A . Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother. 2001; 45(5):1595-8. PMC: 90516. DOI: 10.1128/AAC.45.5.1595-1598.2001. View

McGee L, Wang H, Wasas A, HUEBNER R, Chen M, Klugman K . Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. Microb Drug Resist. 2001; 7(1):55-63. DOI: 10.1089/107662901750152800. View

Seral C, Castillo F, Rubio-Calvo M, Fenoll A, Garcia C, Gomez-Lus R . Distribution of resistance genes tet(M), aph3'-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J Antimicrob Chemother. 2001; 47(6):863-6. DOI: 10.1093/jac/47.6.863. View

Gay K, Stephens D . Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J Infect Dis. 2001; 184(1):56-65. DOI: 10.1086/321001. View

Hoban D, Wierzbowski A, Nichol K, Zhanel G . Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob Agents Chemother. 2001; 45(7):2147-50. PMC: 90618. DOI: 10.1128/AAC.45.7.2147-2150.2001. View

10.

Brandt C, Honscha M, Truong N, Holland R, Hovener B, Bryskier A . Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany. Microb Drug Resist. 2001; 7(2):165-70. DOI: 10.1089/10766290152045039. View

11.

Jacobs J, van Baar G, London N, Tjhie J, Schouls L, Stobberingh E . Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group. Antimicrob Agents Chemother. 2001; 45(8):2375-7. PMC: 90658. DOI: 10.1128/AAC.45.8.2375-2377.2001. View

12.

Facinelli B, Spinaci C, Magi G, Giovanetti E, Varaldo P . Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet. 2001; 358(9275):30-3. DOI: 10.1016/s0140-6736(00)05253-3. View

13.

Perez-Trallero E, Vicente D, Montes M, Marimon J, Pineiro L . High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults. J Antimicrob Chemother. 2001; 48(2):225-9. DOI: 10.1093/jac/48.2.225. View

14.

Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin J . Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother. 2001; 48(2):291-4. DOI: 10.1093/jac/48.2.291. View

15.

Farrell D, Morrissey I, Bakker S, Felmingham D . Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemother. 2001; 48(4):541-4. DOI: 10.1093/jac/48.4.541. View

16.

Aracil B, Minambres M, Oteo J, Torres C, Gomez-Garces J, Alos J . High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J Antimicrob Chemother. 2001; 48(4):592-4. DOI: 10.1093/jac/48.4.592. View

17.

Marchandin H, Jean-Pierre H, Jumas-Bilak E, Isson L, Drouillard B, Darbas H . Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. Pathol Biol (Paris). 2001; 49(7):522-7. DOI: 10.1016/s0369-8114(01)00212-7. View

18.

de Azavedo J, McGavin M, Duncan C, Low D, McGeer A . Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 2001; 45(12):3504-8. PMC: 90860. DOI: 10.1128/AAC.45.12.3504-3508.2001. View

19.

Nagai K, Shibasaki Y, Hasegawa K, Davies T, Jacobs M, Ubukata K . Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother. 2001; 48(6):915-8. DOI: 10.1093/jac/48.6.915. View

20.

Syrogiannopoulos G, Grivea I, Fitoussi F, Doit C, Katopodis G, Bingen E . High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr Infect Dis J. 2001; 20(9):863-8. DOI: 10.1097/00006454-200109000-00008. View